Sign In
Buy PTC
$139.72
-2.62 (-1.84%)
At Close: Jun 03, 2026
PTC's Q3 Earnings & Sales Top, Jump Y/Y, Raised Outlook Boosts Shares
10:32am, Thursday, 31'st Jul 2025
PTC posts a 34% fiscal Q3 2025 EPS beat and raises full-year guidance as AI tools and SaaS momentum fuel 24% revenue growth.
PTC (PTC) Q3 Revenue Jumps 24%
06:19am, Thursday, 31'st Jul 2025
PTC (PTC) Q3 Revenue Jumps 24%
PTC Inc. (PTC) Q3 2025 Earnings Call Transcript
09:20pm, Wednesday, 30'th Jul 2025
PTC Inc. (NASDAQ:PTC ) Q3 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Kristian P. Talvitie - Executive VP & CFO Matthew Shimao - Senior Vice President of Investor Relat
PTC Inc. (PTC) Reports Q3 Earnings: What Key Metrics Have to Say
07:31pm, Wednesday, 30'th Jul 2025
The headline numbers for PTC Inc. (PTC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
PTC Inc. (PTC) Beats Q3 Earnings and Revenue Estimates
06:21pm, Wednesday, 30'th Jul 2025
PTC Inc. (PTC) came out with quarterly earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $0.98 per share a year ago.
Industrial software maker PTC raises annual forecast
04:57pm, Wednesday, 30'th Jul 2025
Industrial software maker PTC raised its annual forecast and beat Wall Street estimates for third-quarter revenue on Wednesday, helped by robust demand for its design software products.
PTC ANNOUNCES THIRD FISCAL QUARTER 2025 RESULTS
04:01pm, Wednesday, 30'th Jul 2025
Solid execution in Q3'25 Constant Currency ARR Growth of 9.3%; at higher end of guidance range Operating and Free Cash Flow Growth of 14%; exceeded guidance ranges Raising guidance for ARR, Free Cash
PTC to Accelerate the Design and Simulation of AI Infrastructure and Complex Products with NVIDIA Omniverse
08:30am, Wednesday, 30'th Jul 2025
Integration of NVIDIA Omniverse libraries to bring CAD and PLM data into real-time simulation and immersive design environments PTC has joined the Alliance for OpenUSD, reinforcing its commitment to
Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
01:58pm, Tuesday, 29'th Jul 2025
The U.S. Food and Drug Administration approved on Monday PTC Therapeutics, Inc.'s PTCT SEPHIENCE (sepiapterin) for children and adult patients with phenylketonuria (PKU).
These Analysts Increase Their Forecasts On PTC Therapeutics
11:23am, Tuesday, 29'th Jul 2025
PTC Therapeutics, Inc. PTCT announced it has gained FDA approval for SEPHIENCE on Monday.
Ahead of PTC Inc. (PTC) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:16am, Tuesday, 29'th Jul 2025
Beyond analysts' top-and-bottom-line estimates for PTC Inc. (PTC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
US FDA approves PTC Therapeutics' metabolic disorder drug
04:25pm, Monday, 28'th Jul 2025
The U.S. Food and Drug Administration has approved PTC Therapeutics' oral drug to treat a rare inherited metabolic disorder that prevents the body from properly breaking down certain amino acids, the
- Broad labeling inclusive of all disease subtypes for individuals 1 month of age and older - - PTC will host a conference call on Monday, July 28 th at 5:00 pm ET - WARREN, N.J. , July 28, 2025 /PRNe
PTC to Announce Q3 Earnings: Here's What You Should Know
12:12pm, Monday, 28'th Jul 2025
PTC expects Q3 revenues of up to $600M and EPS as high as $1.30, driven by AI-powered PLM and CAD momentum.
Forget a Takeover From Autodesk, PTC Is a Great Stock to Buy Anyway. Here's Why.
06:32pm, Sunday, 27'th Jul 2025
PTC (PTC 1.21%) investors were treated to a flurry of excitement in July as, according to reports, its larger peer Autodesk (ADSK 0.78%) took a serious look at acquiring the company only to appear to
